API | oliceridine

oliceridine (Olinvyk) Report issue

Small molecule Approved ^FDA Fast Track ^FDA

AACT ChEMBL MeSH PubChem

Active Ingredient History

NOW

Oliceridine, sold under the brand name Olinvyk, is an opioid medication that is used for the treatment of moderate to severe acute pain in adults. It is given by intravenous (IV) injection. ^Wikipedia

Chemistry

SMILES: COc1ccsc1CNCC[C@]2(CCOC3(CCCC3)C2)c4ccccn4
InChIKey: DMNOVGJWPASQDL-OAQYLSRUSA-N
Mol. Mass: 386.56
ALogP: 4.69 Partition coefficient
ChEMBL Molecule:
oliceridine

More Chemistry

Pharmacology

Mechanism of Action:
- Mu-type opioid receptor (Homo sapiens) ^UniProt
Multi-specific: Missing data
Black Box: No
Availability: Missing data
Delivery Methods: Missing data
Pro Drug: No

Drug Pricing (per unit)

United States

$13.0990 - $82.3400

More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

((3-methoxythiophen-2-yl)methyl)((2-(9-(pyridin-2-yl)-6-oxaspiro(4.5)decan-9-yl)ethyl))amine | oliceridine | trv130 | trv-130

Organizations (7)

Research & Development (7)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Marketing (1)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Indications (4)

Approved Indications (1)

Acute Pain (approved 2020)

Experimental Indications - Clinical Trial Phases 1-4 (4)

Acute Pain (Phase 3)

General Surgery (Phase 3)

Healthy Volunteers (Phase 1)

Pain (Phase 2)

Overview

Highest Phase: Phase 4
# of Trials: 13
# of Trial Organizations: 7

Trials by Phase

Trial	Phase	Start Date	Organizations	Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue